Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Aclarubicin, Low-Dose Cytarabine Combined With G-CSF (CAG) Regimen For Patients Previously Treated Or Ineligible For Intensive Chemotherapy With Acute Myeloid Leukemia and Myelodysplastic Syndrom: A Single Center Experience

Koichiro Minauchi, MD, Masato Obara, MD, PhD, Takahide Ara, MD, Kanako Shima, MD, Atsushi Yasumoto, MD, PhD, Masanobu Nakata, MD, Shuichi Ota, MD, PhD, Kiyotoshi Imai, MD, Ph.D, Teiichi Hirano, MD, Ph.D, Yoshio Kiyama, MD, Masahiro Ogasawara, MD, PhD, Naoki Kobayashi, MD, PhD, Masahiro Imamura, MD, PhD

Blood (2013) 122 (21): 2697.

https://doi.org/10.1182/blood.V122.21.2697.2697

Published: 2013

Journal Articles

Monosomal Karyotype in Myeloid Malignancies Is Prognostically Worse Even After Allogeneic Hematopoietc Stem Cell Transplantaion; Results From Two Transplant Centers,

Minauchi Koichiro, MD, Akio Shigematsu, MD, PhD, Masanobu Nakata, MD, Toshihiro Matsukawa, MD, Koh Ebata, MD, Tomohiro Yamakawa, MD, Tomoyuki Saga, MD, Kanako Shima, MD, Makoto Ibata, MD, PhD, Junichi Sugita, MD, PhD, Shuichi Ota, MD, PhD, Kiyotoshi Imai, MD, Ph.D, Teiichi Hirano, MD, Ph.D, Masahiro Ogasawara, MD, Ph.D, Yoshio Kiyama, MD, Masahiro Imamura, MD, PhD, Naoki Kobayashi, MD, Ph.D

Blood (2011) 118 (21): 4154.

https://doi.org/10.1182/blood.V118.21.4154.4154

Published: 2011

Journal Articles

Efficient Generation of HLA-A24-Restricted WT1-Specific Cytotoxic T Lymphocytes Using Gene-Engineered Artificial Antigen-Presenting Cells

Masahiro Ogasawara, MD, Ph.D, Tomohiro Yamakawa, MD, Yuki Katsura, MD, Kanako Shima, MD, Toshihiro Matsukawa, MD, Minoru Kanaya, MD, Koichiro Minauchi, MD, Masanobu Nakata, MD, Shuichi Ota, MD, PhD, Kiyotoshi Imai, MD, Ph.D, Teiichi Hirano, MD, Ph.D, Naoki Kobayashi, MD, Ph.D, Yoshio Kiyama, MD, Naoto Hirano, MD, Ph.D

Blood (2010) 116 (21): 2101.

https://doi.org/10.1182/blood.V116.21.2101.2101

Published: 2010

Journal Articles

Pre-Treatment Serum Soluble Interleukin-2 Receptor Value Significantly Predicts Survival in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma.

Shinsuke Noguchi, MD, Masanobu Nakata, MD, Kanako Shima, MD, Yuki Katsura, MD, Toshihiro Matsukawa, MD, Minoru Kanaya, MD, Satomi Matsuoka, MD, Mizuha Kosugi, MD, Shiro Fujii, MD, Shuichi Ota, MD, PhD, Kiyotoshi Imai, MD, PhD, Teiichi Hirano, MD, PhD, Naoki Kobayashi, MD, PhD, Masahiro Ogasawara, MD, PhD, Yoshio Kiyama, MD, Masaharu Kasai, MD, PhD

Blood (2009) 114 (22): 3948.

https://doi.org/10.1182/blood.V114.22.3948.3948

Published: 2009

Journal Articles

Imatinib Mesylate Impairs the Function of Human Regulatory T Cells (Tregs) and Reverses the Inhibition of Immune Responses to Imatinib-Resistant CML Cells by Tregs.

Masahiro Ogasawara, Toshihiro Matsukawa, Yuki Katsura, Kanako Shima, Minoru Kanaya, Mizuha Kosugi, Satomi Matsuoka, Shiro Fujii, Shinsuke Noguchi, Shuichi Ota, MD, PhD, Masanobu Nakata, MD, Kiyotoshi Imai, Teiichi Hirano, Naoki Kobayashi, Yoshio Kiyama, MD, Masaharu Kasai, MD, PhD

Blood (2009) 114 (22): 4728.

https://doi.org/10.1182/blood.V114.22.4728.4728

Published: 2009

Journal Articles

Phase II Study of Rituximab Combined with Cladribine and Mitoxantrone in Relapsed or Refractory Indolent Non-Hodgkin’s Lymphoma

Shuichi Ota, MD, Junji Tanaka, MD, Masanobu Nakata, MD, Kiyotoshi Imai, MD, Masahiro Ogasawara, MD, Yoshio Kiyama, MD, Tatsuro Irie, MD, Masanobu Morioka, MD, Shintaro Umehara, MD, Hiroshi Iwasaki, MD, Koji Chiba, MD, Yasutaka Kakinoki, MD, Takashi Fukuhara, MD, Masaharu Kasai, MD, Masahiro Imamura, MD

Blood (2008) 112 (11): 4946.

https://doi.org/10.1182/blood.V112.11.4946.4946

Published: 2008

Journal Articles

The Influence of Cytochrome P450 3A Gene Polymorphisms on Tacrolimus Concentrations in Hematopoetic Stem Cell Transplantation Patients.

Masahiro Ogasawara, Mizuha Kosugi, Satomi Matsuoka, Shinsuke Asamuma, Shinsuke Noguchi, Sirou Fujii, Akinori Wada, Shuichi Ota, Masanobu Nakata, Kiyotoshi Imai, Naoki Kobayashi, Yoshio Kiyama, Masaharu Kasai

Blood (2008) 112 (11): 2230.

https://doi.org/10.1182/blood.V112.11.2230.2230

Published: 2008

Journal Articles

Large Scale Expansion of Human Dendritic Cells with Regulatory Function from Peripheral Blood Monocytes Employing Leukapheresis and Rapamycin for Clinical Trials.

Masahiro Ogasawara, MD, PhD, Shinsuke Asanuma, MD, Shinsuke Noguchi, MD, Atsushi Yasumoto, MD, Akinori Wada, MD, Shuuichi Ohta, MD, PhD, Masanobu Nakata, MD, Kiyotoshi Imai, MD, PhD, Teiichi Hirano, MD, PhD, Naoki Kobayashi, MD, PhD, Yoshio Kiyama, MD, Junji Tanaka, MD, PhD, Masahiro Imamura, MD, PhD, Masaharu Kasai, MD, PhD

Blood (2007) 110 (11): 1204.

https://doi.org/10.1182/blood.V110.11.1204.1204

Published: 2007

Journal Articles

Induction of Survivin-Specific, HLA-A24 Restricted Cytotoxic T Lymphocytes Using an Immunodominant Peptide; In-Vitro Feasibility Study and a Clinical Trial of Survivin Peptide Vaccination.

Masahiro Ogasawara, MD, PhD, Misato Kikuchi, MD, PhD, Satoru Kimura, MD, PhD, Koichiro Kobayashi, MD, PhD, Takayoshi Miyazono, MD, PhD, Masanobu Nakata, MD, PhD, Kiyotoshi Imai, MD, PhD, Teiichi Hirano, MD, PhD, Naoki Kobayashi, MD, PhD, Yoshio Kiyama, MD, PhD, Junji Tanaka, MD, PhD, Masahiro Imamura, MD, PhD, Masaharu Kasai, MD, PhD

Blood (2006) 108 (11): 2709.

https://doi.org/10.1182/blood.V108.11.2709.2709

Published: 2006

Journal Articles

Tacrolimus Concentrations in Hematopoetic Stem Cell Transplantation Patients Are Related to Cytochrome P450 3A5 Gene Polymorphisms.

Koichiro Kobayashi, MD, PhD, Masahiro Ogasawara, MD, PhD, Misato Kikuchi, MD, PhD, Satoru Kimura, MD, PhD, Takayoshi Miyazono, MD, PhD, Masanobu Nakata, MD, PhD, Kiyotoshi Imai, MD, PhD, Teiichi Hirano, MD, PhD, Naoki Kobayashi, MD, PhD, Yoshio Kiyama, MD, PhD, Junji Tanaka, MD, PhD, Masahiro Imamura, MD, PhD, Mitsune Tanimoto, MD, PhD, Masaharu Kasai, MD, PhD

Blood (2006) 108 (11): 2902.

https://doi.org/10.1182/blood.V108.11.2902.2902

Published: 2006

NARROW

Aclarubicin, Low-Dose Cytarabine Combined With G-CSF (CAG) Regimen For Patients Previously Treated Or Ineligible For Intensive Chemotherapy With Acute Myeloid Leukemia and Myelodysplastic Syndrom: A Single Center Experience

Monosomal Karyotype in Myeloid Malignancies Is Prognostically Worse Even After Allogeneic Hematopoietc Stem Cell Transplantaion; Results From Two Transplant Centers,

Efficient Generation of HLA-A24-Restricted WT1-Specific Cytotoxic T Lymphocytes Using Gene-Engineered Artificial Antigen-Presenting Cells

Pre-Treatment Serum Soluble Interleukin-2 Receptor Value Significantly Predicts Survival in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma.

Imatinib Mesylate Impairs the Function of Human Regulatory T Cells (Tregs) and Reverses the Inhibition of Immune Responses to Imatinib-Resistant CML Cells by Tregs.

Phase II Study of Rituximab Combined with Cladribine and Mitoxantrone in Relapsed or Refractory Indolent Non-Hodgkin’s Lymphoma

The Influence of Cytochrome P450 3A Gene Polymorphisms on Tacrolimus Concentrations in Hematopoetic Stem Cell Transplantation Patients.

Large Scale Expansion of Human Dendritic Cells with Regulatory Function from Peripheral Blood Monocytes Employing Leukapheresis and Rapamycin for Clinical Trials.

Induction of Survivin-Specific, HLA-A24 Restricted Cytotoxic T Lymphocytes Using an Immunodominant Peptide; In-Vitro Feasibility Study and a Clinical Trial of Survivin Peptide Vaccination.

Tacrolimus Concentrations in Hematopoetic Stem Cell Transplantation Patients Are Related to Cytochrome P450 3A5 Gene Polymorphisms.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only